Logo image of RIME

ALGORHYTHM HOLDINGS INC (RIME) Stock Fundamental Analysis

NASDAQ:RIME - Nasdaq - US8293225020 - Common Stock - Currency: USD

2.83  -0.29 (-9.29%)

After market: 2.93 +0.1 (+3.53%)

Fundamental Rating

1

Overall RIME gets a fundamental rating of 1 out of 10. We evaluated RIME against 64 industry peers in the Household Durables industry. RIME may be in some trouble as it scores bad on both profitability and health. RIME does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RIME has reported negative net income.
RIME had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: RIME reported negative net income in multiple years.
In multiple years RIME reported negative operating cash flow during the last 5 years.
RIME Yearly Net Income VS EBIT VS OCF VS FCFRIME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

With a Return On Assets value of -287.54%, RIME is not doing good in the industry: 96.88% of the companies in the same industry are doing better.
RIME has a worse Return On Equity (-671.43%) than 93.75% of its industry peers.
Industry RankSector Rank
ROA -287.54%
ROE -671.43%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-31.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RIME Yearly ROA, ROE, ROICRIME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

Looking at the Gross Margin, with a value of 20.72%, RIME is doing worse than 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of RIME has declined.
RIME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.83%
GM growth 5Y-4.28%
RIME Yearly Profit, Operating, Gross MarginsRIME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

3

2. Health

2.1 Basic Checks

RIME does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RIME has been reduced compared to 1 year ago.
The number of shares outstanding for RIME has been increased compared to 5 years ago.
Compared to 1 year ago, RIME has a worse debt to assets ratio.
RIME Yearly Shares OutstandingRIME Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
RIME Yearly Total Debt VS Total AssetsRIME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -8.06, we must say that RIME is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -8.06, RIME is not doing good in the industry: 93.75% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.09 indicates that RIME is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.09, RIME is doing good in the industry, outperforming 76.56% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z -8.06
ROIC/WACCN/A
WACC16.03%
RIME Yearly LT Debt VS Equity VS FCFRIME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

RIME has a Current Ratio of 1.34. This is a normal value and indicates that RIME is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.34, RIME is doing worse than 84.38% of the companies in the same industry.
A Quick Ratio of 1.06 indicates that RIME should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.06, RIME perfoms like the industry average, outperforming 56.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.06
RIME Yearly Current Assets VS Current LiabilitesRIME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for RIME have decreased strongly by -51.38% in the last year.
Looking at the last year, RIME shows a very negative growth in Revenue. The Revenue has decreased by -27.09% in the last year.
RIME shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.76% yearly.
EPS 1Y (TTM)-51.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.68%
Revenue 1Y (TTM)-27.09%
Revenue growth 3Y-19.95%
Revenue growth 5Y-12.76%
Sales Q2Q%-17.85%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RIME Yearly Revenue VS EstimatesRIME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
RIME Yearly EPS VS EstimatesRIME Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2 4 6 8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RIME. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RIME Price Earnings VS Forward Price EarningsRIME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RIME Per share dataRIME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150 -200 -250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RIME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALGORHYTHM HOLDINGS INC

NASDAQ:RIME (6/13/2025, 8:00:02 PM)

After market: 2.93 +0.1 (+3.53%)

2.83

-0.29 (-9.29%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-19 2024-11-19/amc
Earnings (Next)N/A N/A
Inst Owners6.98%
Inst Owner ChangeN/A
Ins Owners0.97%
Ins Owner Change68.39%
Market Cap7.10M
Analysts82.86
Price TargetN/A
Short Float %5.42%
Short Ratio1.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B 1.59
P/tB 2.11
EV/EBITDA N/A
EPS(TTM)-273.57
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.66
FCFYN/A
OCF(TTM)-3.63
OCFYN/A
SpS9.19
BVpS1.78
TBVpS1.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -287.54%
ROE -671.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.72%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-31.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.83%
GM growth 5Y-4.28%
F-Score2
Asset Turnover2.2
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.06
Altman-Z -8.06
F-Score2
WACC16.03%
ROIC/WACCN/A
Cap/Depr(3y)55.88%
Cap/Depr(5y)85.38%
Cap/Sales(3y)0.39%
Cap/Sales(5y)0.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.09%
Revenue growth 3Y-19.95%
Revenue growth 5Y-12.76%
Sales Q2Q%-17.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-979.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1470.17%
OCF growth 3YN/A
OCF growth 5YN/A